A Phase 2, Double Blind, Randomized, Placebo-Controlled, Proof of Concept, Dose Finding Study of Intraarticular Bone Morphogenetic Protein (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee.
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2012
At a glance
- Drugs Eptotermin alfa (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Stryker Corporation
- 31 Jan 2012 Actual patient number is 355 according to ClinicalTrials.gov.
- 31 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jun 2011 New trial record